Access to ABBV-400 Before Official Approval

Sponsor: AbbVie

Expanded Access
Sponsor score: 60
Inactive

ClinicalTrials ID:NCT05982873

Provider View

This program allows eligible patients to access the investigational drug ABBV-400 before it is officially approved by health authorities. A doctor will determine if the potential benefits of taking ABBV-400 outweigh the risks based on the patient's medical history.

Patient Parameters

Program Overview

This program is designed to provide patients with access to ABBV-400, a drug that is not yet approved by health authorities, if they meet certain criteria. The availability of this program depends on the patient's location and eligibility. A medical doctor will assess whether the benefits of using ABBV-400 are greater than the risks for each individual patient.

Eligibility Criteria

Inclusion Criteria

  • The patient must not qualify for any ongoing clinical trials involving ABBV-400.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.